Cradle Cap Shampoo Manufacturer: What a Tear-Free Brief Has to Settle Before Sampling
A cradle cap shampoo manufacturer usually loses the project at a pH number, not at a price. The base has to sit near 5.5 to keep lather out of the eye. The actives that work on Malassezia either live in that window or break the claim.
The public shelf shows the split. A 0.95% zinc pyrithione wash leads several US cradle cap lists, and that active has been prohibited in EU cosmetics since 1 March 2022 under Commission Regulation (EU) 2021/1902. One bottle cannot serve both markets with the same active.
This page sets out what a factory decides, what the law fixes, and what the brief has to contain before the first sample. It is written for the brand that signs the artwork.
What does a cradle cap shampoo manufacturer decide, and what does the law decide?
Three variables decide whether a cradle cap shampoo can ship. The factory controls all three: the surfactant system, the pH window and the active level.
The law fixes the rest. Market, age band and claim wording set the ceiling on the active, the label text and the paperwork. A brief that names all three before the first sample removes most of the rework.
The surfactant system sets how much monomer reaches the eye. The pH window decides which actives stay in solution. The active level decides the preservative, the solubiliser and the foam.
Which decisions a factory cannot make for you
Four inputs come from the brand, not the bench: market of first sale, age on the pack, claim in the artwork, fill volume.
China limits a product for children under three to six claims and prohibits an anti-dandruff claim outright. The same bottle sold in the US would need a Drug Facts panel. A factory can build either version, and it cannot choose between them for you.
Why does the tear-free requirement decide the surfactant system?
A shampoo reaches the eye at roughly a 1:10 to 1:20 dilution in the bath. Irritation data gathered on the neat product describes a dose no infant receives.
Surfactant in water splits into micelles and free monomer. Only the monomer crosses the tear film and binds corneal protein. The head group sets the sting, not the percentage printed on the bottle.
Sodium cocoyl isethionate and sodium methyl cocoyl taurate carry a large polar head and stay mild. Sodium laureth sulfate carries a small charged head and does not. A brief that bans every anionic option removes the mild ones first and keeps the harsh one.
The emollient that softens scale also suppresses lather. Teams recover foam by raising surfactant, and eye exposure rises with it. That loop explains most failures at the sample stage. It costs less to break at the bench than at the panel.
Which actives can a tear-free cradle cap shampoo legally carry?
Four actives dominate cradle cap formulations. Two of them fit a base held at pH 5.0 to 6.0 with a claim that survives in more than one market.
Active | EU limit and status | China | US | Fits a pH 5.5 tear-free base |
Piroctone olamine | Annex V entry 35: 1.0% in rinse-off products, 0.5% in other products | Permitted; anti-dandruff claim barred on a children's product | Cosmetic use only, no monograph active | Yes; soluble above pH 4.5 |
Climbazole | Annex V entry 32: 0.5% as a preservative in rinse-off shampoo; Annex III entry 310 allows 2% as an anti-dandruff agent (Regulation (EU) 2019/698) | Permitted as a preservative; anti-dandruff claim barred on a children's product | Cosmetic use only | Yes, at pH 5.0 to 7.0; needs a solubiliser |
Salicylic acid | Annex III entry 98: 3.0% in rinse-off hair products, not to be used in products for children under three (Regulation (EU) 2019/1966) | Permitted with an age restriction | Monograph active at 1.8% to 3.0% | No; keratolysis needs pH 3.5 to 4.0 |
Zinc pyrithione | Prohibited since 1 March 2022 (Regulation (EU) 2021/1902) | 1.5% in anti-dandruff rinse-off hair products | Monograph active at 0.3% to 2.0% | Yes on chemistry, ruled out in the EU |
No active, emollient only | No restriction | Permitted | Cosmetic | Yes; depends on contact time |
The table explains why one artwork cannot cross borders. A US formula built on 0.95% zinc pyrithione cannot be sold in the EU at all. A Chinese version cannot print the claim that sells it.
Piroctone olamine carries the least friction. It stays soluble at pH 5 and holds a 1.0% ceiling in rinse-off products. It creates no US monograph conflict, because the US treats the claim rather than the ingredient as the trigger.
What can the label claim in the EU, China and the US?
China prohibits an anti-dandruff claim on any children's cosmetic. That one rule decides the artwork for the largest infant care market in Asia.
Claim wording | EU | China | US |
Anti-dandruff, treats cradle cap | Medicinal by presentation under Directive 2001/83/EC | Prohibited on children's cosmetics | Drug claim, OTC monograph, Drug Facts panel |
Helps lift flakes, gently cleanses scale | Cosmetic; needs evidence under Article 20 and Regulation (EU) 655/2013 | Permitted inside the age-appropriate claim list | Cosmetic if no drug claim is implied |
Tear-free | Not a regulated term; needs eye-irritation evidence | Cosmetic claim, no defined test | Cosmetic claim, no defined test |
Soothing, suitable for sensitive scalp | Permitted with support | Permitted for 0 to 3 under the soothing category | Cosmetic |
Why the claim list, not the formula, blocks most launches
An infant product in China may claim cleansing, moisturising, hair care, sun protection, soothing and keeping skin dry, and nothing else. A formulator can put piroctone olamine at 1.0% into that product. Marketing cannot describe what the ingredient does.
The EU takes another route. Any claim needs evidence under Article 20 of Regulation (EC) No 1223/2009 and the Common Criteria in Regulation (EU) No 655/2013. A claim to treat seborrheic dermatitis moves the product into medicines.
The US triggers on the claim rather than the ingredient. A dandruff claim makes the shampoo an OTC monograph drug under 21 CFR part 358. That route needs a Drug Facts panel and a facility registered under the Modernization of Cosmetics Regulation Act.
What has to be in the brief before the first sample?
Eight inputs close the conflict before bench work starts. A brief that omits any of them returns as a second sample round.
Input | What you must decide | What it changes |
Market of first sale | EU, China, US or a single market | Active, claim route, paperwork |
Age on the pack | 0 to 3, 3 to 12, or all ages | Claim list, active ceiling, salicylic acid eligibility |
Claim wording | Treatment, flake lifting, or cleansing only | Cosmetic or drug classification |
Active and level | Piroctone olamine, climbazole, or none | Preservative, solubiliser, pH window |
pH target | 5.0 to 6.0, or lower for keratolysis | Surfactant family, eye comfort, stability |
Surfactant architecture | Glucoside, isethionate, taurate, or a blend | Foam, viscosity, conditioning deposit |
Pack and fill volume | 200 ml bottle, 400 ml pump, aluminium can | MOQ, dilution at use, sting panel design |
Evidence standard | HET-CAM screen plus sting panel, or RhCE | Test calendar, claim file content |
How is a tear-free claim tested and documented?
Tear-free carries no legal definition. A manufacturer has to define it inside the claim file, then prove it at the dilution the bather makes.
Method | Guideline or status | What it measures | Stage |
HET-CAM | No OECD guideline; internal screen | Haemorrhage, lysis and coagulation on the chorioallantoic membrane | Weeks 1 to 2 |
RhCE | OECD TG 492 | Viability of a reconstructed human cornea-like epithelium | 4 weeks |
BCOP | OECD TG 437 | Opacity and permeability of an isolated bovine cornea | 4 weeks |
ICE | OECD TG 438 | Corneal swelling and fluorescein retention | 4 weeks, optional |
Human sting panel | No guideline | Sting score at in-use dilution, immediate and at 30 seconds | 4 weeks |
28-day in-use | No guideline | Scale, erythema and TEWL over repeated washes | 4 weeks |
Run the base without the active first. That isolates the surfactant contribution. Add the active and repeat the dilution series, because a keratolytic at pH 3.5 moves the result further than any surfactant swap.
DEVA Skincare runs CAM irritation work inside a 150-protocol efficacy and safety programme and 72 inspection and process control steps. The batch runs in a 100,000-grade GMPC cleanroom.
What MOQ, sampling and lead time apply to a cradle cap shampoo?
A cradle cap shampoo starts at 5,000 units in a standard bottle. The first saleable batch lands about ten to twelve weeks after the brief.
Item | Figure |
MOQ, standard bottle | 5,000 units |
MOQ, aluminium can | 10,000 units |
Sample lead time | 1 week |
Mass production after sample approval | 6 weeks |
Each efficacy or safety protocol | 4 weeks |
Brief to first saleable batch | 10 to 12 weeks |
Monthly capacity across four plants | 20 million units |
The calendar is set by the tests rather than the mixer. A project that needs an RhCE result, a sting panel and a 28-day in-use trial adds four weeks per protocol. They rarely run in parallel.
How do you audit a cradle cap shampoo manufacturer before you sign?
Six questions separate a factory that has built this product from one that has only filled shampoo. Every answer is checkable in the batch record.
Question | What a good answer contains |
Which eye-irritation method, at what dilution? | HET-CAM at 1:10 plus RhCE, with the dilution printed on the report |
Has this exact base passed a preservative challenge test? | Challenge test on the finished base with the active, not on the base alone |
What stability data covers the active? | Four weeks accelerated plus real time, with assay of the active at each point |
How is the pack qualified? | Xenon lamp ageing and compatibility on the actual bottle and closure |
Who signs the safety assessment? | A named qualified safety assessor, with the CPSR or the Chinese equivalent on file |
Which filings does the factory support? | CPNP notification, MoCRA facility registration, and the Chinese children's cosmetics filing |
Ask for the batch record of a similar product, not a wall of certificates. The record shows the in-process checks, the water quality results and the filling tolerance. Nobody can improvise it on the day of the audit.
DEVA Skincare holds 70 granted patents, 22 special cosmetics certificates and more than 5,000 mature formulas. It fills infant sunscreen and amino acid foam cleanser at 13 million units each a year. Those numbers matter here because the same filling and testing lines carry a cradle cap shampoo.
What do buyers ask before they place a cradle cap shampoo order?
Can a cradle cap shampoo be tear-free and still work on flakes?
Yes, if the active is an azole and the base sits at pH 5.0 to 6.0. Piroctone olamine at up to 1.0% and climbazole both hold in that window. Salicylic acid does not, because keratolysis needs pH 3.5 to 4.0 and sting scores rise there. Emollient contact time covers the gap in a 0 to 3 product.
Is zinc pyrithione still allowed in a cradle cap shampoo?
In the US and China, yes. The EU moved it to Annex II under Commission Regulation (EU) 2021/1902. It has been prohibited in EU cosmetics since 1 March 2022. A formula for the EU needs piroctone olamine, climbazole or an emollient-only route. Check Annex II before you print any claim.
What is the EU limit for piroctone olamine in a shampoo?
Annex V entry 35 of Regulation (EC) No 1223/2009 sets 1.0% in rinse-off products and 0.5% in other products. The ceiling is a legal maximum, not a formulation target. Micelles hold part of the dose, so most shampoos sit near the top of the range.
Can a children's shampoo in China claim anti-dandruff?
No. Chinese rules limit an infant product to six claim categories and prohibit an anti-dandruff claim on children's cosmetics. The 3 to 12 band adds four categories, and anti-dandruff is not one of them. The active can stay in the formula; the label cannot describe what it does.
Why does salicylic acid rule out a newborn formula?
Annex III entry 98, as replaced by Commission Regulation (EU) 2019/1966, bars salicylic acid from products for children under three. The keratolytic dose also needs pH 3.5 to 4.0, which fails an eye-comfort screen. Emollient contact time replaces that step. A 3 to 12 product can still carry it at 3.0% in a rinse-off hair product.
What is the MOQ and lead time for a cradle cap shampoo?
DEVA Skincare starts at 5,000 units in a standard bottle and 10,000 in an aluminium can. A sample takes one week, mass production takes six weeks after approval, and each efficacy protocol runs four weeks. Plan ten to twelve weeks from brief to first saleable batch.
What does tear-free mean in law?
Nothing specific. No regulation defines the term and no OECD guideline covers it. The claim still needs evidence under Article 20 of Regulation (EC) No 1223/2009 and the Common Criteria in Regulation (EU) No 655/2013. The claim file has to state the method and the dilution.
Send the brief for your tear-free cradle cap shampoo through the quote form on this page. Name the market of first sale, the age band, the claim you intend to print and the first batch volume. A cradle cap shampoo manufacturer can answer those four lines. Expect a base, a legal active level and a test plan at in-use dilution.
Comments